Table 3 Comparison of HPV prevalence across various age groups in different years [n(%)]
Year | N | <30 | 30 ~ 39 | 40 ~ 49 | 50 ~ 59 | ≥ 60 |
|---|---|---|---|---|---|---|
2016 | 310 | 9(2.90) | 55(17.74) | 119(38.39) | 84(27.10) | 43(13.87) |
2017 | 415 | 23(5.54) | 60(14.46) | 156(37.59) | 101(24.34) | 75(18.07) |
2018 | 428 | 20(4.67) | 71(16.59) | 166(38.79) | 95(22.20) | 76(17.75) |
2019 | 462 | 21(4.55) | 86(18.61) | 156(33.77) | 142(30.74) | 57(12.33) |
2020 | 478 | 17(3.56) | 95(19.87) | 155(32.43) | 122(25.52) | 89(18.62) |
2021 | 834 | 49(5.88) | 200(23.98) | 218(26.14) | 234(28.06) | 133(15.94) |
2022 | 532 | 44(8.27) | 123(23.12) | 151(28.38) | 143(26.88) | 71(13.35) |
2023 | 886 | 75(8.47) | 240(27.09) | 231(26.07) | 219(24.72) | 121(13.65) |
\(\:{x}^{2}\) | Â | 28.231 | 44.314 | 51.411 | 12.059 | 15.815 |
P |  | < 0.001 | < 0.001 | < 0.001 | 0.099 | 0.027 |